Additionally, upon stratifying the dataset according to tumor molecular subtype, the model demonstrated promising outcomes with AUCs of 0.824, 0.823, 0.844, and 0.803 for luminal A, luminal B, HER2-enriched, and TN tumors, respectively. This evidence concerns the gene ERBB2 and neoplasm.